News and Press Releases
Biocair increases customer support with the expansion of its Hamburg site
September 17 2024 – Hamburg, Germany –Benefitting from close links to the airport, Biocair’s Hamburg facility now offers an enhanced package of support following an expansion. As a leading global...
Category: Logistics
Posted: September 17, 2024
Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market
September 17 2024 –BOVENAU, Germany, – Richter BioLogics GmbH & Co KG, the microbial biologics affiliate of Gedeon Richter Plc. celebrated the opening of its new cutting-edge biopharmaceutical cGMP facility in...
Category: BioManufacturing
Posted: September 17, 2024
Suhrenkamp 59, D-22335 Hamburg
Northway’s 20th birthday was celebrated at Sapiehas Palace with famous guests
14 September 2024 –Vilnius, Lithuania – On Thursday evening, around 100 guests gathered at the Sapiehas Palace in Vilnius to celebrate the 20th birthday of the „Northway Group“. Today, the group crosses not...
Category: Biotechnology
Posted: September 16, 2024
Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer
Results from the pivotal Phase III ARANOTE trial evaluating darolutamide plus androgen deprivation therapy (ADT) showed a statistically significant increase in radiological progression-free survival (rPFS) compared to placebo plus ADT...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 16, 2024
Novartis Kisqali shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer
Invasive disease-free survival benefit continued to increase after completion of the three-year treatment period across all patient subgroups, including those with node-negative disease Results remain consistent across secondary endpoints, including...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 16, 2024
Book a meeting with Gaelic Laboratories at CPHI Milan!
Gaelic Laboratories is pleased to be exhibiting at CPHI Milan. Visit us in Hall 5 to learn more about our advanced Beta-Lactam manufacturing and packaging facilities, and our newly-equipped laboratories...
Category: Biotechnology, Drug Discovery
Posted: September 16, 2024
Old Waterford Rd, Gurtnafleur, Clonmel, Co. Tipperary, E91 CD92 Ireland
ILC Therapeutics completes £2.5m financing and bolsters C-suite
Owain Millington appointed CEO, Julie Bailey appointed CFO and Dawn Firmin appointed COO Financing to support pre-clinical development of ILCT’s two lead assets 11 September 2024 -- Glasgow, UK --...
Category:
Posted: September 13, 2024
CPHI Annual Report 2024: CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years
Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years 12 September 2024 – Milan, Italy – Ahead of CPHI Milan – the...
Category: Pharmaceutical
Posted: September 12, 2024
KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF
Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression, following a recent £90m Series A financing 12 September 2024:...
Category: BioManufacturing, Biotechnology
Posted: September 12, 2024
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the...
Category: Biotechnology, Other
Posted: September 12, 2024
Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair
10 September 2024 – London, UK Coronado Research is a consultancy-led, professional services organisation operating in the clinical development arena. The company will help pharmaceutical and biotechnology companies optimise their drug...
Category:
Posted: September 11, 2024
MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test
11 September 2024 -- Cambridge, UK -- MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test...
Category: Biotechnology, Other
Posted: September 11, 2024
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...
Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
EORTC Extends Medidata Partnership to Help Power New Phased of Oncology Research
Medidata technology deployed to increase access to and transform the patient experience for cancer trials 11 September 2024 -- London, UK -- Medidata, a Dassault Systèmes brand and leading provider...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 11, 2024
AI can detect lung nodules that could lead to lung cancer nearly 3 years before symptoms and actual diagnosis, study finds
Evidence presented at 2024 World Conference on Lung Cancer highlights chest X-ray AI’s potential to detect lung nodules early and expedite patient care 10 September 2024 -- New York, US...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 10, 2024
C/O RODl & Partner Legal Limited, 170 Edmund Street, Birmingham, United Kingdom B3 2HB 74909
